[Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]].
D000208:Acute Disease; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018771:Arthralgia / Q000188:drug therapy / Q000451:nursing; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000451:nursing*; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D000077613:Etoricoxib; D006073:Gout / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects; D010003:Osteoarthritis / Q000188:drug therapy / Q000451:nursing*; D010147:Pain Measurement / Q000451:nursing; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects; D013450:Sulfones / Q000008:administration & dosage* / Q000009:adverse effects
D018501:Antirheumatic Agents; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib; D007213:Indomethacin